期刊文献+

雌二醇经丝苏氨酸蛋白激酶激活核因子κB通路对子宫内膜癌Ishikawa细胞增殖迁移的影响 被引量:11

Estradiol enhances the proliferation and migration of Ishikawa cells by promotion of angiogenesis induced by activation of NF-κB via AKT pathway
原文传递
导出
摘要 目的 探讨雌二醇在子宫内膜癌Ishikawa细胞中是否通过丝苏氨酸蛋白激酶(AKT)介导核因子κB (NF-κB)通路产生细胞因子,及其对细胞增殖及迁移的影响.方法 Western blot法检测雌二醇作用Ishikawa细胞后AKT活化情况,以及AKT和ER抑制剂对雌二醇活化AKT的影响,TransAM NF-κB p65检测不同浓度雌二醇及1×10^-6 mol/L雌二醇作用不同时间后的NF-κB活性水平.经雌二醇(雌二醇组)、ER抑制剂(ER组)、AKT抑制剂(AKT组)和NF-κB抑制剂(NF-κB组)分别预处理Ishikawa细胞后,采用荧光定量PCR检测细胞内血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF) mRNA表达,Western blot法检测VEGF、bFGF蛋白的变化,流式细胞仪检测细胞周期的变化,羟基荧光素二醋酸盐琥珀酰亚胺脂(CFSE)法检测细胞增殖能力,Transwell检测细胞迁移能力.结果 Western blot检测结果显示,雌二醇、AKT和ER抑制剂作用Ishikawa细胞后AKT活性水平分别为0.090±0.075、0.013 ±0.036、0.042±0.008,对照组为0.053±0.036;雌二醇组的AKT活性值比对照组、ER组及AKT组升高,差异均有统计学意义(P<0.05).TransAM检测显示,雌二醇浓度为1×10^-6mol/L时,Ishikawa细胞NF-κB活性为0.77±0.20,较对照组(0.51±0.16)明显升高,差异有统计学意义(P<0.05);1×10^-6mol/L雌二醇作用30 min及1h时,Ishikawa细胞NF-κB活性水平最高(P<0.05).AKT组NF-κB活性为0.54±0.27,低于1×10^-6mol/L雌二醇组(P<0.05).雌二醇组VEGF、bFGF mRNA的表达分别为6.34±0.45和1.58 ±0.12,明显高于对照组的0.83±0.03和0.34±0.02(均P<0.01);雌二醇组VEGF、bFGF蛋白的表达均明显高于对照组、ER组、AKT组和NF-κB组(均P<0.05).雌二醇作用Ishikawa细胞后,细胞增殖数明显增多,G0/G1期比例明显低于对照组(均P<0.01).结论 雌二醇可能经AKT激活NF-κB通路产生VEGF和bFG因子,促进Ishikawa细胞的增殖与迁移能力。 Objective The aim of this study was to explore whether estradiol induces the expression of VEGF and bFGF in the endometrial cancer Ishikawa cells by activation of NF-κB via AKT pathway,and its effect on cell proliferation.Methods Western blot was used to detect the AKT protein expression in Ishikawa cells after stimulation with estradiol,and the effect of AKT inhibitor or ER inhibitor on the activation of AKT.TransAM kit was used to detect the NF-κB p65 activity.qPCR and Western blot were used to detect the expression of VEGF and bFGF mRNA and proteins in the Ishikawa cells after estradiol treatment (E2 group),and pretreated with AKT inhibitor (AKT group) or ER inhibitor (ER group) or NFκB inhibitor (NF-κB group),following the estradiol treatment.Flow cytometry and CFSE (carboxyfluorescein diacetate,succinimidyl ester) staining were used to examine the cell proliferation.Transwell was used to detect the migration ability of Ishikawa cells.Results Expression of p-AKT protein in the Ishikawa cells was markedly higher than that in the control group (P 〈 0.05).Expressions of p-AKT protein in the AKT and ER groups were significantly decreased than that in the E2 group (P 〈 0.05).The NF-κB activity was highest after stimulation with 1 × 10^-6 mol/L estradiol for 30 min to 1 h.AKT inhibitor significantly reduced the NF-κB activity (P 〈 0.05).The expressions of VEGF and bFGF mRNA and proteins in the E2 group were significantly increased than that in the control group (P 〈 0.05),and their expression in the AKT,ER and NF-κB groups were significantly decreased than that in the E2 group (P 〈 0.05).The proliferation and migration abihties of the Ishikawa cells were significantly increased after estradiol stimulation.Conclusions Estradiol induces the production of VEGF and bFGF through activating NF-κB via AKT pathway,and enhances the proliferation and migration ability of cancer cells.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2014年第11期811-815,共5页 Chinese Journal of Oncology
基金 国家自然科学基金(81160318) 广西自然科学丛金(2013GXNSFAA019219)
关键词 子宫内膜肿瘤 雌二醇 丝苏氨酸蛋白激酶 核因子ΚB 细胞增殖 细胞运动 Endometrial neoplasms Estradiol AKT NF-κ B Cell proliferation Cell movement
  • 相关文献

参考文献10

  • 1Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways [ J ]. Steroids, 2009, 74 (7) :622-627.
  • 2Meyer MR, Haas E, Pmssnitz ER, et al. Non-genomic regnlatiou of vascular cell function and growth by estrogen [ J ]. Mol Cell Endocrinol, 2009, 308(1-2) :9-16.
  • 3Guo RX, Wei LH, Tu Z, et al. 1713-estradiol activates PI.3K/Akt signaling pathway by estrogen receptor (ER) -dependent and ER- independent mechanisms in endometrial cancer cells[J]. J Steroid Biochem Mol Biol, 2006, 99( 1 ) :9-18.
  • 4Gustin JA, Korgaonkar CK, Pincheira R, et al. Akt regulates basal and induced processing of NF-KB (pl00) to p52 [ J]. J Biol Chem, 2006, 281 (24) :16473-16481.
  • 5Stice JP, Mbai FN, Chen L, et al. Rapid activation of nuclear factor-KB by 17f3-estradiol and selective estrogen receptor modulators : pathways mediating cellular protection [ J ]. Shock, 2012, 38(2) :128-136.
  • 6Engelman JA. Targeting PI3 K signalling in cancer: opportunities, challenges and limitations [ J ]. Nat Rev Cancer, 2009, 9 ( 8 ) : 550-562.
  • 7Xie TX, Xia Z, mng N, et al. Constitutive NF-KB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep, 2010, 23 (3) :725-732.
  • 8Dai H, Zhao S, Xu L, et al. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue [ J ]. Oncol Rep, 2010, 23 ( 3 ) : 795-799.
  • 9陆媛媛,张洁清,梁少凤,李力.雌激素通过激活AKT通路产生的细胞因子增强子宫内膜癌细胞增殖能力[J].中国癌症杂志,2013,23(11):868-873. 被引量:10
  • 10Nakabayashi H, Shimizu K. Involvement of Akt/NF-KB pathway in antitumor effects of pathenolide on glioblastoma cells in vitro and vivo[J]. BMC Cancer, 2012, 12:453.

二级参考文献8

  • 1汤建民,何权瀛,常秀军.磷酸化Akt和PTEN在非小细胞肺癌组织中的表达及其相关性[J].中国癌症杂志,2005,15(6):541-545. 被引量:6
  • 2MATHEWS J, WIHLEN B, TUJAGUE M, et al. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters [ J ] . Mol Endoerinol, 2006, 20(3): 534-543.
  • 3GUO R X, WEI L H, TU Z, et al. 1713 -Estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells [ J ]. J Steroid Biochem Mol Biol, 2006, 99(1): 9-18.
  • 4SKINNER H D, ZHENG J Z, FANG J, et al. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1 alpha, HDM2 and p70S6K1 in response to phosphatidylinositol 3 kinase/AKT signaling [ J ] . J Biol Chem, 2004, 279 (44): 45643- 45651.
  • 5JANG Y J, KIM D S, JEON 0 H, et al. Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells [ J ] . J Biochem MolBiol, 2007, 40(3): 439-443.
  • 6MOLDOVAN N I. Angiogenesis, I' enfant terrible of vascular biology is coming of age [ J ] . J Cell Mol Med, 2005, 9(4): 775-776.
  • 7PRESTA M. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenoearcinoma ceils: implications for the neovascularization of normal and neoplastic endometrium [ J ] . J Cell Physiol, 1998, 137(3): 593-597.
  • 8丁兰芳,王晓谦,陆媛媛,宋红林,李力,张洁清.雌二醇对子宫内膜癌细胞AKT通路中细胞因子的影响[J].中国肿瘤临床,2011,38(20):1262-1266. 被引量:6

共引文献9

同被引文献112

  • 1Ortega E, Marti RM, Yeramian A, et al. Targeted therapies in gynecologic cancers and melanoma[J]. Semin Diagn Pathol, 2008,25:262-273.
  • 2Gozgit JM, Squillace RM, Wongchenko MJ, et al. Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models[J]. Cancer Chemother Pharmacol, 2013,71:1315-1323.
  • 3Treeck O, Diedrich K, Ortmann O. The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines[J].Eur J Cancer, 2003, 39:1302-1309.
  • 4Suga S, Kato K, Ohgami T, et al. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer[J]. Gynecol Oncol, 2007, 105:341-350.
  • 5Sadaria MR, Yu JA, Meng X, et al. Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway[J].Anticancer Res, 2013,33: 1337-1342.
  • 6Presta M. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: implications for the neovascularization of normal and neoolastic endometrium[J]. J Cell Phvsiol, 1988,137:593-597.
  • 7Ogunro P S,Bolarinde A A,Owa O O,et al.Antioxidant status and reproductive hormones in women during reproductive,perimenopausal and postmenopausal phase of life[J].Afr J Med Sci,2014,43(1):49~57.
  • 8Loreti N,Ambao V,Juliato C T,et al.Carbohydrate complexity and proportion of serum FSH isoforms reflect pituitaryovarian activity in perimenopausal women and depot medroxyprogesterone acetate users[J].Clin Endocrinol(Oxf),2009,71(4):558~565.
  • 9Guset G, Costi S, Lazar E, et al. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma [ J ]. Rom J Morphol Embryol, 2010,51 ( 4 ) : 677 - 682.
  • 10Banno K, Kisu I,Yanokura M,et al. Biomarkers in endometrial canc- er : possible clinical applications ( Review ) [ J ]. Oncol Lett, 2012,3 (6) :1175 - 1180.

引证文献11

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部